Attached files
| file | filename |
|---|---|
| 8-K - PEAK PHARMACEUTICALS, INC. | form8kitem401appointmentofau.htm |
EXHIBIT 16.1
MaloneBailey, LLP
9801 Westheimer, Suite 1100
Houston, Texas 77042
October 12, 2015
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read Item 4.01 of Form 8-K of Peak Pharmaceuticals, Inc. for the event that occurred on October 9, 2015, and we agree with the statements concerning our firm contained therein.
Very truly yours,
/s/ MaloneBailey, LLP
www.malone-bailey.com